These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 29408369)
21. Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance. Tye MA; Payne NC; Johansson C; Singh K; Santos SA; Fagbami L; Pant A; Sylvester K; Luth MR; Marques S; Whitman M; Mota MM; Winzeler EA; Lukens AK; Derbyshire ER; Oppermann U; Wirth DF; Mazitschek R Nat Commun; 2022 Aug; 13(1):4976. PubMed ID: 36008486 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of protein synthesis and malaria parasite development by drug targeting of methionyl-tRNA synthetases. Hussain T; Yogavel M; Sharma A Antimicrob Agents Chemother; 2015 Apr; 59(4):1856-67. PubMed ID: 25583729 [TBL] [Abstract][Full Text] [Related]
23. Competitive Inhibition of Okanin against Yang G; Liang Y; Li X; Li Z; Qin Y; Weng Q; Yan Y; Cheng Y; Qian Y; Sun L Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731970 [TBL] [Abstract][Full Text] [Related]
24. Structure of Prolyl-tRNA Synthetase-Halofuginone Complex Provides Basis for Development of Drugs against Malaria and Toxoplasmosis. Jain V; Yogavel M; Oshima Y; Kikuchi H; Touquet B; Hakimi MA; Sharma A Structure; 2015 May; 23(5):819-829. PubMed ID: 25817387 [TBL] [Abstract][Full Text] [Related]
30. Exploration of aminoacyl-tRNA synthetases from eukaryotic parasites for drug development. Gill J; Sharma A J Biol Chem; 2023 Mar; 299(3):102860. PubMed ID: 36596362 [TBL] [Abstract][Full Text] [Related]
31. A dual-targeted aminoacyl-tRNA synthetase in Plasmodium falciparum charges cytosolic and apicoplast tRNACys. Pham JS; Sakaguchi R; Yeoh LM; De Silva NS; McFadden GI; Hou YM; Ralph SA Biochem J; 2014 Mar; 458(3):513-23. PubMed ID: 24428730 [TBL] [Abstract][Full Text] [Related]
32. Aminoacyl-tRNA synthetases as drug targets. Lukarska M; Palencia A Enzymes; 2020; 48():321-350. PubMed ID: 33837708 [TBL] [Abstract][Full Text] [Related]
33. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation. Pandey RK; Narula A; Naskar M; Srivastava S; Verma P; Malik R; Shah P; Prajapati VK J Biomol Struct Dyn; 2017 Mar; 35(4):791-804. PubMed ID: 26984239 [TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors. Murillo-Solano C; Dong C; Sanchez CG; Pizarro JC Malar J; 2017 Jul; 16(1):292. PubMed ID: 28724415 [TBL] [Abstract][Full Text] [Related]
35. Aminoacylation of Plasmodium falciparum tRNA(Asn) and insights in the synthesis of asparagine repeats. Filisetti D; Théobald-Dietrich A; Mahmoudi N; Rudinger-Thirion J; Candolfi E; Frugier M J Biol Chem; 2013 Dec; 288(51):36361-71. PubMed ID: 24196969 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of Plasmodium falciparum phenylalanine tRNA synthetase provides opportunity for antimalarial drug development. Sharma M; Mutharasappan N; Manickam Y; Harlos K; Melillo B; Comer E; Tabassum H; Parvez S; Schreiber SL; Sharma A Structure; 2022 Jul; 30(7):962-972.e3. PubMed ID: 35460612 [TBL] [Abstract][Full Text] [Related]
37. Crystal structures of Plasmodium falciparum cytosolic tryptophanyl-tRNA synthetase and its potential as a target for structure-guided drug design. Koh CY; Kim JE; Napoli AJ; Verlinde CL; Fan E; Buckner FS; Van Voorhis WC; Hol WG Mol Biochem Parasitol; 2013 May; 189(1-2):26-32. PubMed ID: 23665145 [TBL] [Abstract][Full Text] [Related]
38. In silico assessment of natural products and approved drugs as potential inhibitory scaffolds targeting aminoacyl-tRNA synthetases from Doshi K; Pandya N; Datt M 3 Biotech; 2020 Nov; 10(11):470. PubMed ID: 33088666 [TBL] [Abstract][Full Text] [Related]
39. Evolutionary and structural annotation of disease-associated mutations in human aminoacyl-tRNA synthetases. Datt M; Sharma A BMC Genomics; 2014 Dec; 15(1):1063. PubMed ID: 25476837 [TBL] [Abstract][Full Text] [Related]
40. Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin. Hoepfner D; McNamara CW; Lim CS; Studer C; Riedl R; Aust T; McCormack SL; Plouffe DM; Meister S; Schuierer S; Plikat U; Hartmann N; Staedtler F; Cotesta S; Schmitt EK; Petersen F; Supek F; Glynne RJ; Tallarico JA; Porter JA; Fishman MC; Bodenreider C; Diagana TT; Movva NR; Winzeler EA Cell Host Microbe; 2012 Jun; 11(6):654-63. PubMed ID: 22704625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]